Step 1 Result:
['SCA_AGENT_MEMORY_BEFORE: 1363951616', "AnnData object with n_obs × n_vars = 39516 × 33538\n    obs: 'label', 'group', 'source_file', 'batch'\n    var: 'gene_ids', 'feature_types'\n\nMetadata keys: Index(['label', 'group', 'source_file', 'batch'], dtype='object')\n\nVariable gene keys: Index(['gene_ids', 'feature_types'], dtype='object')\n\nShape of the data: (39516, 33538)", 'Set of variables used:\n - n_pcs: 40\n - n_neighbors: 10\n - resolution: 0.7', "Ranking genes grouped by 'leiden' using method 'wilcoxon'...", "Top 5 marker genes per 'leiden' cluster:\nCluster 0: PERP, KRT19, KRT5, TACSTD2, KRT15\nCluster 1: S100P, KRT19, SCGB1A1, PTGDS, PHLDA2\nCluster 2: CLDN4, ELF3, WFDC2, RARRES1, KRT19\nCluster 3: KRT13, TACSTD2, CLDN5, CLDN4, LCN2\nCluster 4: MT-ND1, MT-ND4, MT-CO1, MT-CO2, MT-ND2\nCluster 5: MSLN, MDK, KRT19, WFDC2, ADIRF\nCluster 6: CCL5, CCL4, CD8A, LINC01871, CD7\nCluster 7: NPY, MT-ND4, MT-ND2, IL7R, MT-CO2\nCluster 8: LTB, TRBC2, IL7R, BTG1, CXCR4\nCluster 9: NKX3-1, KLK4, SORD, MSMB, KLK2\nCluster 10: HBA1, HBA2, HBB, NEAT1, ELF3\nCluster 11: MS4A1, CD79A, CD74, HLA-DRA, CD83\nCluster 12: MALAT1, MT-CO1, MT-ND2, MT-ND1, BTG1\nCluster 13: MT-CO2, MT-ND4, MT-CO1, NPY, MT-ND2\nCluster 14: HLA-DRA, CD74, HLA-DPA1, HLA-DPB1, HLA-DRB1\nCluster 15: OLFM4, SCGB3A1, LCN2, RARRES1, PIGR\nCluster 16: HLA-DRB1, HLA-DQA1, HLA-DRA, HLA-DPB1, LYZ\nCluster 17: GPR183, LYZ, HLA-DQA1, HLA-DRB1, APOC1\nCluster 18: S100A9, LYZ, CTSS, SOD2, IL1B\nCluster 19: NPY, PCA3, GOLM1, FOLH1, SPOCK1\nCluster 20: TPSAB1, CPA3, TPSB2, MS4A2, HPGDS\nCluster 21: AGR2, NKX3-1, CLDN3, GOLM1, KLK2\nCluster 22: VWF, SPARCL1, IFI27, ENG, IGFBP4\nCluster 23: SPARCL1, IGFBP7, VIM, IFI27, IFITM3\nCluster 24: SPARC, IGFBP7, VWF, GNG11, INSR\nCluster 25: GZMK, GZMA, CCL5, CCL4, CXCR4\nCluster 26: ACPP, KLK3, MSMB, KLK2, AZGP1\nCluster 27: NKG7, KLRD1, CST7, GNLY, GZMA\nCluster 28: CALD1, RGS5, IGFBP7, MYL9, TAGLN\nCluster 29: MYL9, TAGLN, ACTA2, WFDC2, KRT13\nCluster 30: DCN, FBLN1, IGFBP7, LUM, MGP\nCluster 31: A2M, CLEC14A, PTPRB, CLDN5, IFI27\nCluster 32: LCN2, PIGR, OLFM4, RARRES1, WFDC2\nCluster 33: CXCL1, LTF, MMP7, OLFM4, MT2A\nCluster 34: KRT13, S100P, MSMB, KRT19, RND3\nPreprocessing complete. `adata` has been saved as adata_preprocessed.h5ad.\nSCA_AGENT_MEMORY_AFTER: 1211629568"]

Step 2 Result:
["SCA_AGENT_MEMORY_BEFORE: 1349779456\nCells: 33717, Genes: 4000\nAvailable layers: []\nObsm keys: ['X_pca', 'X_umap']\n\n=== obs metadata (for visualization) ===\n[CAT] label (8 categories) → ['P3t', 'P2t', 'P1n', 'P4n', 'P3n', 'P4t', 'P2n', 'P1t']\n[CAT] group (2 categories) → ['Tumor', 'Normal']\n[CAT] source_file (8 categories) → ['GSM5793831_P3t', 'GSM5793829_P2t', 'GSM5793824_P1n', 'GSM5793827_P4n', 'GSM5793826_P3n', 'GSM5793832_P4t', 'GSM5793825_P2n', 'GSM5793828_P1t']\n[CAT] batch (8 categories) → ['0', '1', '2', '3', '4', '5', '6', '7']\n[NUM] n_genes (range=201.00 ~ 12207.00)\n[NUM] n_genes_by_counts (range=201.00 ~ 12207.00)\n[NUM] log1p_n_genes_by_counts (range=5.31 ~ 9.41)\n[NUM] total_counts (range=175.21 ~ 4418.91)\n[NUM] log1p_total_counts (range=5.17 ~ 8.39)\n[NUM] total_counts_mt (range=0.00 ~ 76.86)\n[NUM] log1p_total_counts_mt (range=0.00 ~ 4.35)\n[NUM] pct_counts_mt (range=0.00 ~ 10.00)\n[CAT] leiden (35 categories) → ['0', '6', '13', '19', '9', '14', '22', '7'] ...\n=======================================\n\nCell category distribution across groups:\ngroup                                  Normal  Tumor\ncell_category                                       \nB Cells                                   644    302\nBasal Epithelial Cells                   1782   1043\nCytotoxic T Cells                         710    591\nDendritic Cells / APC                     737   1222\nEndothelial Cells                        1054    747\nEndothelial-Mesenchymal Transitioning     908    259\nErythroid Cells                            16      0\nGoblet-like Secretory Cells                44      0\nLuminal Differentiated Cells             1871    702\nLuminal Progenitor Cells                   23      0\nMast Cells                                352    441\nMitochondrial-rich Cells                 2041   4514\nMixed Epithelial Cells                     21      0\nMonocytes                                  13      0\nMyeloid Cells                             394    316\nMyofibroblasts / Mesenchymal Cells         39      4\nNK Cells                                    2    253\nNPY-expressing Epithelial Cells             1   2254\nNaive/Memory T Cells                      901   1195\nNatural Killer Cells                      441    350\nPancreatic-like Epithelial Cells           26      0\nPericytes / Smooth Muscle Cells           830    446\nProstate Secretory Cells                  878   1525\nSecretory Goblet-like Cells               188      0\nSmooth Muscle Cells                        12      0\nStromal Fibroblasts                       250     39\nT Cells (Cytotoxic)                      1268   1680\nTumor-derived Luminal Cells               191    197\nSCA_AGENT_MEMORY_AFTER: 1361461248"]

Step 3 Result:
['SCA_AGENT_MEMORY_BEFORE: 1325596672', "Current Group:Tumor\n{'MT1X': {'DEG': [{'cell_type': 'Basal Epithelial Cells', 'pval': 2.0101882778648324e-37, 'score': 12.784161567687988, 'logFC': 1.279355764389038, 'pval_adj': 1.4986826548755937e-34}], 'TF enrichment': [{'Term': 'Mineral absorption', 'adj_pval': 0.0062233188055383}]}, 'CALD1': {'DEG': [{'cell_type': 'Basal Epithelial Cells', 'pval': 3.3005089285207414e-29, 'score': 11.218709945678711, 'logFC': 1.1983420848846436, 'pval_adj': 7.334464285601648e-27}, {'cell_type': 'Prostate Secretory Cells', 'pval': 2.426004136945111e-13, 'score': 7.322937488555908, 'logFC': 0.47246187925338745, 'pval_adj': 3.130327918638853e-11}], 'TF enrichment': [{'Term': 'Vascular smooth muscle contraction', 'adj_pval': 0.3312592132165087}]}, 'APOC1': {'DEG': [{'cell_type': 'Dendritic Cells / APC', 'pval': 1.946778286056674e-43, 'score': 13.819402694702148, 'logFC': 2.6020450592041016, 'pval_adj': 7.787113144226696e-40}], 'TF enrichment': [{'Term': 'Cholesterol metabolism', 'adj_pval': 0.3312592132165087}]}, 'CTSD': {'DEG': [{'cell_type': 'Dendritic Cells / APC', 'pval': 1.8804252357304001e-37, 'score': 12.789348602294922, 'logFC': 1.695533037185669, 'pval_adj': 2.5072336476405335e-34}], 'TF enrichment': [{'Term': 'Lysosome', 'adj_pval': 0.3312592132165087}]}, 'KLK3': {'DEG': [{'cell_type': 'Dendritic Cells / APC', 'pval': 5.0610293071238495e-30, 'score': 11.38336181640625, 'logFC': 1.933750033378601, 'pval_adj': 3.374019538082566e-27}, {'cell_type': 'Mitochondrial-rich Cells', 'pval': 1.5335951261988874e-40, 'score': 13.330744743347168, 'logFC': 1.3463525772094727, 'pval_adj': 3.067190252397775e-37}], 'TF enrichment': [{'Term': 'Pathways in cancer', 'adj_pval': 0.3312592132165087}]}, 'APOE': {'DEG': [{'cell_type': 'Dendritic Cells / APC', 'pval': 5.366383312311679e-26, 'score': 10.544840812683105, 'logFC': 1.9059237241744995, 'pval_adj': 2.385059249916302e-23}], 'TF enrichment': [{'Term': 'Cholesterol metabolism', 'adj_pval': 0.3312592132165087}]}, 'FTL': {'DEG': [{'cell_type': 'Mitochondrial-rich Cells', 'pval': 7.70228156983706e-21, 'score': 9.36365795135498, 'logFC': 0.73336261510849, 'pval_adj': 4.401303754192605e-18}], 'TF enrichment': [{'Term': 'Mineral absorption', 'adj_pval': 0.0062233188055383}]}, 'PLA2G2A': {'DEG': [{'cell_type': 'Mitochondrial-rich Cells', 'pval': 2.520376281074481e-09, 'score': 5.960129737854004, 'logFC': 2.791335105895996, 'pval_adj': 6.721003416198616e-07}, {'cell_type': 'Prostate Secretory Cells', 'pval': 2.2111035338310863e-42, 'score': 13.643366813659668, 'logFC': 1.973432183265686, 'pval_adj': 8.844414135324344e-39}], 'TF enrichment': [{'Term': 'Vascular smooth muscle contraction', 'adj_pval': 0.3312592132165087}]}, 'NKX3-1': {'DEG': [{'cell_type': 'Mitochondrial-rich Cells', 'pval': 2.7983691646098486e-08, 'score': 5.553605556488037, 'logFC': 1.1612553596496582, 'pval_adj': 6.218598143577442e-06}], 'TF enrichment': [{'Term': 'Pathways in cancer', 'adj_pval': 0.3312592132165087}]}, 'GADD45G': {'DEG': [{'cell_type': 'Prostate Secretory Cells', 'pval': 4.3470931921080335e-14, 'score': 7.550164222717285, 'logFC': 1.0359978675842285, 'pval_adj': 6.9553491073728536e-12}], 'TF enrichment': [{'Term': 'Pathways in cancer', 'adj_pval': 0.3312592132165087}]}, 'PLCG2': {'DEG': [{'cell_type': 'Luminal Differentiated Cells', 'pval': 4.083547235512528e-48, 'score': 14.574457168579102, 'logFC': 1.2048594951629639, 'pval_adj': 1.4849262674591013e-45}], 'TF enrichment': [{'Term': 'Pathways in cancer', 'adj_pval': 0.3312592132165087}]}, 'SDC2': {'DEG': [{'cell_type': 'Luminal Differentiated Cells', 'pval': 4.43909245340453e-46, 'score': 14.25068473815918, 'logFC': 2.57088303565979, 'pval_adj': 1.1837579875745414e-43}], 'TF enrichment': [{'Term': 'Fluid shear stress and atherosclerosis', 'adj_pval': 0.3312592132165087}]}, 'IL7R': {'DEG': [{'cell_type': 'T Cells (Cytotoxic)', 'pval': 6.003403637316523e-18, 'score': 8.63248348236084, 'logFC': 0.8221091628074646, 'pval_adj': 4.8027229098532186e-15}, {'cell_type': 'NK Cells', 'pval': 2.2042468106671918e-08, 'score': 5.595155239105225, 'logFC': 0.6066939234733582, 'pval_adj': 1.1021234053335959e-05}], 'TF enrichment': [{'Term': 'Pathways in cancer', 'adj_pval': 0.3312592132165087}, {'Term': 'Hematopoietic cell lineage', 'adj_pval': 0.3450361497633865}]}, 'STAT4': {'DEG': [{'cell_type': 'T Cells (Cytotoxic)', 'pval': 8.704103093866103e-12, 'score': 6.826450824737549, 'logFC': 0.4932156503200531, 'pval_adj': 1.9342451319702454e-09}, {'cell_type': 'NK Cells', 'pval': 2.1967539874947667e-06, 'score': 4.734426498413086, 'logFC': 0.5400851368904114, 'pval_adj': 0.0006759243038445437}], 'TF enrichment': [{'Term': 'Th1 and Th2 cell differentiation', 'adj_pval': 0.3312592132165087}, {'Term': 'Pathways in cancer', 'adj_pval': 0.3312592132165087}]}, 'CCL5': {'DEG': [{'cell_type': 'NK Cells', 'pval': 1.0566711847992312e-11, 'score': 6.7985639572143555, 'logFC': 0.8648421168327332, 'pval_adj': 2.1133423695984623e-08}], 'TF enrichment': [{'Term': 'Rheumatoid arthritis', 'adj_pval': 0.3312592132165087}]}, 'CTSL': {'DEG': [{'cell_type': 'NK Cells', 'pval': 4.132913549074017e-09, 'score': 5.8787841796875, 'logFC': 1.685962200164795, 'pval_adj': 2.7552756993826778e-06}], 'TF enrichment': [{'Term': 'Rheumatoid arthritis', 'adj_pval': 0.3312592132165087}, {'Term': 'Lysosome', 'adj_pval': 0.3312592132165087}, {'Term': 'Fluid shear stress and atherosclerosis', 'adj_pval': 0.3312592132165087}]}, 'MAF': {'DEG': [{'cell_type': 'NK Cells', 'pval': 1.9983298935674427e-05, 'score': 4.265077114105225, 'logFC': 0.45120763778686523, 'pval_adj': 0.004701952690746924}], 'TF enrichment': [{'Term': 'Th1 and Th2 cell differentiation', 'adj_pval': 0.3312592132165087}]}}\nGene sets by disease type:\nDisease Group: Tumor, Gene Set: {'MT1X': {'DEG': [{'cell_type': 'Basal Epithelial Cells', 'pval': 2.0101882778648324e-37, 'score': 12.784161567687988, 'logFC': 1.279355764389038, 'pval_adj': 1.4986826548755937e-34}], 'TF enrichment': [{'Term': 'Mineral absorption', 'adj_pval': 0.0062233188055383}]}, 'CALD1': {'DEG': [{'cell_type': 'Basal Epithelial Cells', 'pval': 3.3005089285207414e-29, 'score': 11.218709945678711, 'logFC': 1.1983420848846436, 'pval_adj': 7.334464285601648e-27}, {'cell_type': 'Prostate Secretory Cells', 'pval': 2.426004136945111e-13, 'score': 7.322937488555908, 'logFC': 0.47246187925338745, 'pval_adj': 3.130327918638853e-11}], 'TF enrichment': [{'Term': 'Vascular smooth muscle contraction', 'adj_pval': 0.3312592132165087}]}, 'APOC1': {'DEG': [{'cell_type': 'Dendritic Cells / APC', 'pval': 1.946778286056674e-43, 'score': 13.819402694702148, 'logFC': 2.6020450592041016, 'pval_adj': 7.787113144226696e-40}], 'TF enrichment': [{'Term': 'Cholesterol metabolism', 'adj_pval': 0.3312592132165087}]}, 'CTSD': {'DEG': [{'cell_type': 'Dendritic Cells / APC', 'pval': 1.8804252357304001e-37, 'score': 12.789348602294922, 'logFC': 1.695533037185669, 'pval_adj': 2.5072336476405335e-34}], 'TF enrichment': [{'Term': 'Lysosome', 'adj_pval': 0.3312592132165087}]}, 'KLK3': {'DEG': [{'cell_type': 'Dendritic Cells / APC', 'pval': 5.0610293071238495e-30, 'score': 11.38336181640625, 'logFC': 1.933750033378601, 'pval_adj': 3.374019538082566e-27}, {'cell_type': 'Mitochondrial-rich Cells', 'pval': 1.5335951261988874e-40, 'score': 13.330744743347168, 'logFC': 1.3463525772094727, 'pval_adj': 3.067190252397775e-37}], 'TF enrichment': [{'Term': 'Pathways in cancer', 'adj_pval': 0.3312592132165087}]}, 'APOE': {'DEG': [{'cell_type': 'Dendritic Cells / APC', 'pval': 5.366383312311679e-26, 'score': 10.544840812683105, 'logFC': 1.9059237241744995, 'pval_adj': 2.385059249916302e-23}], 'TF enrichment': [{'Term': 'Cholesterol metabolism', 'adj_pval': 0.3312592132165087}]}, 'FTL': {'DEG': [{'cell_type': 'Mitochondrial-rich Cells', 'pval': 7.70228156983706e-21, 'score': 9.36365795135498, 'logFC': 0.73336261510849, 'pval_adj': 4.401303754192605e-18}], 'TF enrichment': [{'Term': 'Mineral absorption', 'adj_pval': 0.0062233188055383}]}, 'PLA2G2A': {'DEG': [{'cell_type': 'Mitochondrial-rich Cells', 'pval': 2.520376281074481e-09, 'score': 5.960129737854004, 'logFC': 2.791335105895996, 'pval_adj': 6.721003416198616e-07}, {'cell_type': 'Prostate Secretory Cells', 'pval': 2.2111035338310863e-42, 'score': 13.643366813659668, 'logFC': 1.973432183265686, 'pval_adj': 8.844414135324344e-39}], 'TF enrichment': [{'Term': 'Vascular smooth muscle contraction', 'adj_pval': 0.3312592132165087}]}, 'NKX3-1': {'DEG': [{'cell_type': 'Mitochondrial-rich Cells', 'pval': 2.7983691646098486e-08, 'score': 5.553605556488037, 'logFC': 1.1612553596496582, 'pval_adj': 6.218598143577442e-06}], 'TF enrichment': [{'Term': 'Pathways in cancer', 'adj_pval': 0.3312592132165087}]}, 'GADD45G': {'DEG': [{'cell_type': 'Prostate Secretory Cells', 'pval': 4.3470931921080335e-14, 'score': 7.550164222717285, 'logFC': 1.0359978675842285, 'pval_adj': 6.9553491073728536e-12}], 'TF enrichment': [{'Term': 'Pathways in cancer', 'adj_pval': 0.3312592132165087}]}, 'PLCG2': {'DEG': [{'cell_type': 'Luminal Differentiated Cells', 'pval': 4.083547235512528e-48, 'score': 14.574457168579102, 'logFC': 1.2048594951629639, 'pval_adj': 1.4849262674591013e-45}], 'TF enrichment': [{'Term': 'Pathways in cancer', 'adj_pval': 0.3312592132165087}]}, 'SDC2': {'DEG': [{'cell_type': 'Luminal Differentiated Cells', 'pval': 4.43909245340453e-46, 'score': 14.25068473815918, 'logFC': 2.57088303565979, 'pval_adj': 1.1837579875745414e-43}], 'TF enrichment': [{'Term': 'Fluid shear stress and atherosclerosis', 'adj_pval': 0.3312592132165087}]}, 'IL7R': {'DEG': [{'cell_type': 'T Cells (Cytotoxic)', 'pval': 6.003403637316523e-18, 'score': 8.63248348236084, 'logFC': 0.8221091628074646, 'pval_adj': 4.8027229098532186e-15}, {'cell_type': 'NK Cells', 'pval': 2.2042468106671918e-08, 'score': 5.595155239105225, 'logFC': 0.6066939234733582, 'pval_adj': 1.1021234053335959e-05}], 'TF enrichment': [{'Term': 'Pathways in cancer', 'adj_pval': 0.3312592132165087}, {'Term': 'Hematopoietic cell lineage', 'adj_pval': 0.3450361497633865}]}, 'STAT4': {'DEG': [{'cell_type': 'T Cells (Cytotoxic)', 'pval': 8.704103093866103e-12, 'score': 6.826450824737549, 'logFC': 0.4932156503200531, 'pval_adj': 1.9342451319702454e-09}, {'cell_type': 'NK Cells', 'pval': 2.1967539874947667e-06, 'score': 4.734426498413086, 'logFC': 0.5400851368904114, 'pval_adj': 0.0006759243038445437}], 'TF enrichment': [{'Term': 'Th1 and Th2 cell differentiation', 'adj_pval': 0.3312592132165087}, {'Term': 'Pathways in cancer', 'adj_pval': 0.3312592132165087}]}, 'CCL5': {'DEG': [{'cell_type': 'NK Cells', 'pval': 1.0566711847992312e-11, 'score': 6.7985639572143555, 'logFC': 0.8648421168327332, 'pval_adj': 2.1133423695984623e-08}], 'TF enrichment': [{'Term': 'Rheumatoid arthritis', 'adj_pval': 0.3312592132165087}]}, 'CTSL': {'DEG': [{'cell_type': 'NK Cells', 'pval': 4.132913549074017e-09, 'score': 5.8787841796875, 'logFC': 1.685962200164795, 'pval_adj': 2.7552756993826778e-06}], 'TF enrichment': [{'Term': 'Rheumatoid arthritis', 'adj_pval': 0.3312592132165087}, {'Term': 'Lysosome', 'adj_pval': 0.3312592132165087}, {'Term': 'Fluid shear stress and atherosclerosis', 'adj_pval': 0.3312592132165087}]}, 'MAF': {'DEG': [{'cell_type': 'NK Cells', 'pval': 1.9983298935674427e-05, 'score': 4.265077114105225, 'logFC': 0.45120763778686523, 'pval_adj': 0.004701952690746924}], 'TF enrichment': [{'Term': 'Th1 and Th2 cell differentiation', 'adj_pval': 0.3312592132165087}]}}\nSCA_AGENT_MEMORY_AFTER: 1395621888"]

Step 4 Result:
### Comprehensive Report: Target Gene Identification in Human Prostate Adenocarcinoma Single-Cell Data

#### **Overview**
This dataset examines single-cell RNA sequencing data from human prostate adenocarcinoma samples, including both tumor and benign tissues. Differentially expressed genes (DEGs) were analyzed across distinct cell types within these tissues, and transcription factor (TF) pathway enrichments were assessed to provide insights into the biological functions associated with these genes. The goal of this report is to identify key target genes relevant to prostate cancer biology based on statistical significance, fold changes, biological relevance, and pathway involvement.

#### Key Indicators Used for Analysis
1. **DEG Criteria**:
   - Extremely low p-values (<1e-20).
   - High adjusted p-values (pval_adj) indicating robust statistical significance.
   - Fold change (logFC ≥ 1) to capture meaningful differential expression.
   - DEG activity across multiple cell types strengthens the gene's relevance.
   
2. **TF Enrichment**:
   - Pathway association with cancer biology or organ-specific processes (e.g., immune function, metabolism).
   - Lower adjusted p-values for TF enrichment suggest biological importance.

3. **Cell Type Contribution**:
   - Genes consistently upregulated in prostate-relevant cell types (e.g., Prostate Secretory Cells, Basal Epithelial Cells, Luminal Differentiated Cells) within the tumor environment.

---

### **Identified Target Genes**
#### **High-Priority Genes**
The following genes possess the highest statistical significance and biological relevance based on DEG and pathway analysis.

1. **MT1X**:
   - **Cell Type**: Basal Epithelial Cells.
   - **DEG Stats**: pval = 2.01e-37, score = 12.78, logFC = 1.28, pval_adj = 1.49e-34.
   - **Pathway Enrichment**: Mineral absorption (adj_pval = 0.0062).
   - **Reasoning**: Strong statistical significance and unique association with mineral absorption pathways, which may relate to tumor microenvironment regulation. 

2. **APOC1**:
   - **Cell Type**: Dendritic Cells / APC.
   - **DEG Stats**: pval = 1.94e-43, score = 13.82, logFC = 2.60, pval_adj = 7.78e-40.
   - **Pathway Enrichment**: Cholesterol metabolism (adj_pval = 0.33).
   - **Reasoning**: APOC1 showed the highest fold change across DEGs and association with cholesterol metabolism, significant for cancer cell membrane synthesis or immune regulation.

3. **PLA2G2A**:
   - **Cell Types**: Mitochondrial-rich Cells and Prostate Secretory Cells.
   - **DEG Stats**:
     - Mitochondrial-rich Cells: pval = 2.52e-09, score = 5.96, logFC = 2.79, pval_adj = 6.72e-07.
     - Prostate Secretory Cells: pval = 2.21e-42, score = 13.64, logFC = 1.97, pval_adj = 8.84e-39.
   - **Pathway Enrichment**: Vascular smooth muscle contraction.
   - **Reasoning**: PLA2G2A is known for its role in inflammation and cancer progression. Its consistent upregulation across multiple prostate-relevant cell types makes it highly relevant.

4. **KLK3**:
   - **Cell Types**: Dendritic Cells / APC and Mitochondrial-rich Cells.
   - **DEG Stats**:
     - APC: pval = 5.06e-30, score = 11.38, logFC = 1.93, pval_adj = 3.37e-27.
     - Mitochondrial-rich Cells: pval = 1.53e-40, score = 13.33, logFC = 1.35, pval_adj = 3.06e-37.
   - **Pathway Enrichment**: Pathways in cancer.
   - **Reasoning**: KLK3, also known as prostate-specific antigen (PSA), is a well-known biomarker of prostate cancer. Its strong DEG stats reaffirm its importance.

5. **SDC2**:
   - **Cell Type**: Luminal Differentiated Cells.
   - **DEG Stats**: pval = 4.43e-46, score = 14.25, logFC = 2.57, pval_adj = 1.18e-43.
   - **Pathway Enrichment**: Fluid shear stress and atherosclerosis.
   - **Reasoning**: High fold change and relevance in cancer-related pathways.

---

#### **Supporting Genes**
While the following genes are not as statistically dominant as the high-priority genes, they are nonetheless biologically relevant and merit further investigation:

1. **CTSD**:
   - **Cell Type**: Dendritic Cells / APC.
   - **DEG Stats**: pval = 1.88e-37, score = 12.79, logFC = 1.70, pval_adj = 2.50e-34.
   - **Pathway Enrichment**: Lysosome.
   - **Reasoning**: Lysosomal pathways in APCs suggest a role in immunomodulation and tumor growth.

2. **CALD1**:
   - **Cell Types**: Basal Epithelial Cells, Prostate Secretory Cells.
   - **DEG Stats**:
     - Basal Cells: pval = 3.30e-29, score = 11.22, logFC = 1.20, pval_adj = 7.33e-27.
     - Secretory Cells: pval = 2.42e-13, score = 7.32, logFC = 0.47, pval_adj = 3.13e-11.
   - **Pathway Enrichment**: Vascular smooth muscle contraction.
   - **Reasoning**: Relevant in tumor cell motility and invasion.

3. **GADD45G**:
   - **Cell Type**: Prostate Secretory Cells.
   - **DEG Stats**: pval = 4.34e-14, score = 7.55, logFC = 1.03, pval_adj = 6.95e-12.
   - **Pathway Enrichment**: Pathways in cancer.
   - **Reasoning**: Known involvement in stress responses and apoptosis.

4. **FTL**:
   - **Cell Type**: Mitochondrial-rich Cells.
   - **DEG Stats**: pval = 7.70e-21, score = 9.36, logFC = 0.73, pval_adj = 4.40e-18.
   - **Pathway Enrichment**: Mineral absorption (adj_pval = 0.0062).
   - **Reasoning**: Iron metabolism may contribute to oxidative stress, relevant in cancer progression.

---

### **Potential Pathways of Interest**
Based on TF enrichment analyses, the following pathways are notable:
1. **Pathways in Cancer**:
   - Genes: KLK3, NKX3-1, PLCG2, STAT4, GADD45G.
   - Suggests direct relevance in tumor growth and survival mechanisms.

2. **Cholesterol Metabolism**:
   - Genes: APOC1, APOE.
   - Cholesterol regulation may impact tumor microenvironment and cell signaling.

3. **Mineral Absorption**:
   - Genes: MT1X, FTL.
   - Highlights potential roles in nutrient and metal ion homeostasis in cancer.

4. **Vascular Smooth Muscle Contraction**:
   - Genes: CALD1, PLA2G2A.
   - Implicated in tumor vascular remodeling.

---

### **Conclusion**
Based on differential expression and pathway relevance, the genes **MT1X, APOC1, PLA2G2A, KLK3, and SDC2** emerge as the most promising targets in prostate adenocarcinoma. These genes should be prioritized for experimental validation and mechanistic studies. Supporting genes such as **CTSD, CALD1, GADD45G, and FTL** also provide valuable insights into cancer-related pathways and warrant additional investigation.

This comprehensive analysis integrates single-cell data and biological context to identify meaningful genetic targets, paving the way for further exploration in prostate cancer research and therapeutic development.

